Clinical and electrophysiological study of the peripheral nervous system in the elderly

1993 ◽  
Vol 240 (5) ◽  
pp. 263-268 ◽  
Author(s):  
P. Bouche ◽  
F. Cattelin ◽  
O. Saint-Jean ◽  
J. M. L�ger ◽  
S. Queslati ◽  
...  
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
Electrophysiological Study ◽  
The Elderly

CLINICALAND ELECTROPHYSIOLOGICAL STUDY OF THE PERIPHERAL NERVOUS SYSTEM IN THE ELDERLY PEOPLE IN DARBHANGA

2021 ◽  
pp. 19-21
Author(s):  
Nutan Bala ◽  
Priyanka Priyanka ◽  
Sheela Kumari ◽  
Debarshi Jana
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
Linear Models ◽  
Electrophysiological Study ◽  
The Elderly ◽  
Elderly Subjects ◽  
Neurophysiological Studies ◽  
Age Dependent ◽  
Young Subjects ◽  
Effect Of Age

The effect of age on the peripheral nervous system was investigated by clinical examination and neurophysiological studies in 59 subjects aged 60- 103 years and 23 young subjects. Afull laboratory screen for factors which, though clinically silent, may constitute risk factors (RFs) for peripheral neuropathy was also performed in the elderly subjects. Our ndings show that the presence of RFs affects exceptionally the electrophysiological parameters in a statistically signicant way. The age-dependent changes in nerve conduction parameters were well predicted by non-linear models. The simultaneous electromyographical study demonstrates the re-innervation capacity of the motor system

P1-18-07. Longitudinal electrophysiological study of the peripheral nervous system in xeroderma pigmentosum group A

2019 ◽  
Vol 130 (10) ◽  
pp. e214
Author(s):  
Yukio Tsuji ◽  
Takehiro Ueda ◽  
Masahiro Nishiyama ◽  
Fumio Kanda ◽  
Chikako Nishigori ◽  
...  
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
Xeroderma Pigmentosum ◽  
Electrophysiological Study ◽  
Group A ◽  
Xeroderma Pigmentosum Group A

Neuropathies in the older patient

2006 ◽  
Vol 16 (2) ◽  
pp. 113-124 ◽  
Author(s):  
Yusuf A Rajabally
Keyword(s):  
Nervous System ◽  
Peripheral Neuropathy ◽  
Peripheral Nervous System ◽  
Peripheral Nerves ◽  
Elderly Population ◽  
Natural Aging ◽  
The Elderly ◽  
Impaired Glucose Metabolism ◽  
Older Patient ◽  
Target Organs

Peripheral neuropathy encompasses disorders of the peripheral nervous system, affecting the axon and/or the myelin sheath. The prevalence of peripheral neuropathy increases with age. Thought to be of about 3000 per 100 000 in adults generally, this figure could be as high as 8000 above the age of 60 years. However more than half of these cases would be due to impaired glucose metabolism in its various forms. In the remainder, an aetiology may be found in about 70% of cases. The elderly population is at higher risk of peripheral neuropathy, as there is a correlation between age and impairment of the peripheral nervous system. The natural aging process affects adversely the function of peripheral nerves and of their target organs, resulting in the development of motor, sensory and autonomic symptoms in the absence of additional damage of other causes. In addition, the increased prevalence of chronic systemic disorders causing neuropathy, as well as the use of neurotoxic drugs in older patients, contribute to the onset of neuropathy.

Clinical and electrophysiological data on the peripheral nervous system in the elderly

1990 ◽  
Vol 75 ◽  
pp. S13-S14
Author(s):  
P. Bouche ◽  
O. Saint-Jean ◽  
F. Cattelin ◽  
H.P. Cathala ◽  
D. Guez ◽  
...  
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
The Elderly ◽  
Electrophysiological Data

Glucuronyl 3-sulfate occurs exclusively on distal unmyelinated terminals of selected sensory neurons in the peripheral nervous system

1995 ◽  
Vol 53 ◽  
pp. 958-959
Author(s):  
S.S. Spicer ◽  
B.A. Schulte
Keyword(s):  
Central Nervous System ◽  
Nervous System ◽  
Cerebral Cortex ◽  
Peripheral Nervous System ◽  
Sensory Neurons ◽  
Sensory Nerves ◽  
Tissue Antigens ◽  
The Central Nervous System ◽  
The Brain ◽  
Leu 7

Generation of monoclonal antibodies (MAbs) against tissue antigens has yielded several (VC1.1, HNK- 1, L2, 4F4 and anti-leu 7) which recognize the unique sugar epitope, glucuronyl 3-sulfate (Glc A3- SO4). In the central nervous system, these MAbs have demonstrated Glc A3-SO4 at the surface of neurons in the cerebral cortex, the cerebellum, the retina and other widespread regions of the brain.Here we describe the distribution of Glc A3-SO4 in the peripheral nervous system as determined by immunostaining with a MAb (VC 1.1) developed against antigen in the cat visual cortex. Outside the central nervous system, immunoreactivity was observed only in peripheral terminals of selected sensory nerves conducting transduction signals for touch, hearing, balance and taste. On the glassy membrane of the sinus hair in murine nasal skin, just deep to the ringwurt, VC 1.1 delineated an intensely stained, plaque-like area (Fig. 1). This previously unrecognized structure of the nasal vibrissae presumably serves as a tactile end organ and to our knowledge is not demonstrable by means other than its selective immunopositivity with VC1.1 and its appearance as a densely fibrillar area in H&E stained sections.

Questions and Answers

2000 ◽  
Vol 5 (2) ◽  
pp. 3-3
Author(s):  
Christopher R. Brigham ◽  
James B. Talmage
Keyword(s):  
Nervous System ◽  
Peripheral Nervous System ◽  
Spinal Nerve ◽  
Sensory Loss ◽  
Residual Symptoms ◽  
Additional Information ◽  
Questions And Answers ◽  
Motor Nerves ◽  
Symptoms And Signs ◽  
Limited Motion

Abstract Lesions of the peripheral nervous system (PNS), whether due to injury or illness, commonly result in residual symptoms and signs and, hence, permanent impairment. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) describes procedures for rating upper extremity neural deficits in Chapter 3, The Musculoskeletal System, section 3.1k; Chapter 4, The Nervous System, section 4.4 provides additional information and an example. The AMA Guides also divides PNS deficits into sensory and motor and includes pain within the former. The impairment estimates take into account typical manifestations such as limited motion, atrophy, and reflex, trophic, and vasomotor deficits. Lesions of the peripheral nervous system may result in diminished sensation (anesthesia or hypesthesia), abnormal sensation (dysesthesia or paresthesia), or increased sensation (hyperesthesia). Lesions of motor nerves can result in weakness or paralysis of the muscles innervated. Spinal nerve deficits are identified by sensory loss or pain in the dermatome or weakness in the myotome supplied. The steps in estimating brachial plexus impairment are similar to those for spinal and peripheral nerves. Evaluators should take care not to rate the same impairment twice, eg, rating weakness resulting from a peripheral nerve injury and the joss of joint motion due to that weakness.

Sign in / Sign up

Export Citation Format

Share Document